Analyst Update: JPMorgan Chase, SolarCity, Myriad Genetics

Analysts adjusted their ratings on JPMorgan Chase & Co. (JPM), SolarCity Corp (SCTY), and Myriad Genetics, Inc. (MYGN)

Aug 25, 2015 at 12:17 PM
facebook twitter linkedin


Analysts are weighing in today on Dow component JPMorgan Chase & Co. (NYSE:JPM), renewable energy firm SolarCity Corp (NASDAQ:SCTY), and diagnostics expert Myriad Genetics, Inc. (NASDAQ:MYGN). Here's a quick roundup of today's brokerage notes on JPM, SCTY, and MYGN.

  • SCTY is more than 3.5% higher at $45.41, after Cowen and Company started coverage with a "market perform" rating and a $50 price target. News also surfaced that SolarCity Corp caught the eye of Chairman Elon Musk, who purchased 123,510 shares. The stock has since backed off from its intraday high of $47.82 and still faces significant overhead pressure from several trendlines. The good news for those bullish on the solar energy stock is that a rather significant 47% of its float is sold short. Should today's news cause bears to buy back their shorted shares, SCTY could benefit from a short-covering rally. The equity was recently the subject of heavy option activity, as well.
  • Our final stock for today is MYGN, which is more than 8% higher at $34.02, after Wells Fargo elevated the stock's rating to "outperform" from "market perform." Myriad Genetics, Inc. may be benefiting from short-covering activity. As with SCTY, 47% of MYGN's float is sold short. Moreover, the equity's short-interest ratio (SIR) of 71.20 suggests it would take 71 days to exhaust the current reserve of shorted shares, at typical volumes. On a longer-term technical basis, though, the stock is barely above its year-to-date breakeven mark.

For other stocks in analysts' crosshairs, read Analyst Upgrades: Apple Inc., Canadian Solar Inc., and Bank of America Corp and Analyst Downgrades: Micron Technology, Inc., Schlumberger Limited, and Sunedison Inc

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

 


 


 
Special Offers from Schaeffer's Trading Partners